Back to search
Aegerion Pharmaceuticals Limited
08114919
active
Private Limited Company
Health Score
65 / 100
Some Concerns
25/30
Filing
0/30
Financial
40/40
Risk
No risk factors detected.
Details
C/O CSC CLS (UK) LIMITED 5 CHURCHILL PLACE, LONDON, E14 5HU
Incorporated 21/06/2012
Compliance
Accounts
Up to date
Confirmation statement
Up to date
Industry
46460
Wholesale of pharmaceutical goodsOfficers
Mr Matthew Hammond Wiggetts
secretary · Since 26/05/2023
Mr Andrew Philip Dickinson
director · Since 26/05/2023
DIRECTOR
BRITISH · ENGLAND · Age 55
Also on 5 other boards
Mr Matthew Hammond Wiggetts Llb
director · Since 26/05/2023
DIRECTOR
BRITISH · ENGLAND · Age 54
Also on 4 other boards
Persons with Significant Control
Amryt Pharma Holdings Limited
75–100% shares
75–100% votes
Appoint directors
Dept 920a, 196 High Road, London, N22 8HH
Reg: 05316808 · Companies House · Private Limited Company
Notified 24/09/2019
Former PSCs
Aegerion Pharmaceuticals, Inc.
Ceased 29/11/2016
Novelion Therapeutics Inc.
Ceased 24/09/2019
Charges0 outstanding
Charge
satisfied
ARES CAPITAL CORPORATION (AS ADMINISTRATIVE AGENT)
Created 18/02/2022Registered 22/02/2022Satisfied 19/04/2023
Charge
satisfied
CANTOR FITZGERALD SECURITIES (AS ADMINISTRATIVE AGENT)
Created 22/11/2019Registered 28/11/2019Satisfied 19/04/2023
Charge
satisfied
CANTOR FITZGERALD SECURITIES (AS ADMINISTRATIVE AGENT)
Created 24/09/2019Registered 27/09/2019Satisfied 02/03/2022